Proliferative Glomerulonephritis in Lupus Patients With Human Immunodeficiency Virus Infection: A Difficult Clinical Challenge

Seminars in Arthritis and Rheumatism

Volumn 40, Issue 3, 2010, Pages 201-209

  Gindea, Simona ^a   Schwartzman, Julie ^a   Herlitz, Leal C ^b   Rosenberg, Michael ^a   Abadi, Jacobo ^a   Putterman, Chaim ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Diffuse proliferative glomerulonephritis; Human immunodeficiency virus; Mycophenolate mofetil; Systemic lupus erythematosus

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CREATININE; DOUBLE STRANDED DNA ANTIBODY; GLUCOCORTICOID; IMMUNOGLOBULIN G ANTIBODY; LAMIVUDINE; LOPINAVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RALTEGRAVIR; RIBONUCLEOPROTEIN ANTIBODY; RITONAVIR; SM ANTIBODY; UREA; ZIDOVUDINE;

ADULT; CASE REPORT; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; FATALITY; FOCAL GLOMERULONEPHRITIS; HEMATURIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE COMPLEX DEPOSITION; KIDNEY BIOPSY; KNEE ARTHRITIS; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE COUNT; MALAISE; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RASH; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINE SEDIMENT; VIRAL PHARYNGITIS; WEIGHT REDUCTION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-RETROVIRAL AGENTS; BIOPSY; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; GLOMERULONEPHRITIS; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MYCOPHENOLIC ACID; TREATMENT OUTCOME;

EID: 78649443327     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2009.12.001     Document Type: Review

References (66)

1. Winchester R., Bernstein D.H., Fischer H.D., Enlow R., Solomon G. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Int Med 1987, 106:19-26.
2. Patel N., Patel N., Espinoza L.R. HIV infection and rheumatic diseases: the changing spectrum of clinical enigma. Rheum Dis Clin North Am 2009, 35:139-161.
3. Calabrese L.H., Kirchner E., Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active anti-retroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 2005, 35:166-174.
4. Barthel H.R., Wallace D.J. False-positive human immunodeficiency virus testing in patients with lupus erythematosus. Semin Arthritis Rheum 1993, 23:1-7.
5. Kopelman R.G., Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988, 84:82-88.
6. Strauss J., Anitbol C., Zilleruelo G., Scott G., Paredes A., Malaga S., et al. Renal disease in children with acquired immunodeficiency syndrome. N Engl J Med 1989, 321:625-630.
7. D'Agati V., Siegle R. Coexistence of AIDS and lupus nephritis: A case report. Am J Nephrol 1990, 10:243-247.
8. Yeh C., Fox P.C., Goto Y., Austin H.A., Brahim J.S., Fox C.H. Human immunodeficiency virus (HIV) and HIV infected cells in saliva and salivary glands of a patient with systemic lupus erythematosus. J Rheumatol 1992, 19:1810-1812.
9. Bambery P., Deodhar S.D., Malhotra H.S., Sehgal S. Blood transfusion related HBV and HIV infection in a patient with SLE. Lupus 1993, 2:203-205.
10. Itoh K., Nishioka Y., Hirohata S., Inoue T., Ito K., Kimura M., et al. HIV induced systemic lupus erythematosus. Lupus 1994, 3:205-206.
11. Lu I., Cohen P.R., Grossman M.E. Multiple dermatofibromas in a woman with HIV infection and systemic lupus erythematosus. J Am Acad Dermatol 1995, 32:901-903.
12. Byrd V.M., Sergent J.S. Suppression of systemic lupus erythematosus by the human immunodeficiency virus. J Rheumatol 1996, 23:1295-1296.
13. Furie R.A. Effects of human immunodeficiency virus infection on the expression of rheumatic illness. Rheum Dis Clin North Am 1991, 17:177-188.
14. Jindal R., Solomon M., Burruws L. False positive tests for HIV in a woman with lupus and renal failure. N Engl J Med 1993, 328:1281-1282.
15. Molina J.F., Citera G., Rosler D., Cuellar M.L., Molin J., Felipe O., et al. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. J Rheumatol 1995, 22:347-350.
16. Kudava Y.C., Peterson L.S., Holley K.E., Wright A.J., Hunder G.G. SLE nephropathy in a patient with HIV infection: case report and review of the literature. J Rheumatol 1996, 23:1811-1815.
17. Contreras G., Green D.F., Pardo V., Schultz D.R., Bourgoignie J.J. Systemic lupus erythematosus in two adults with human immunodeficiency virus infection. Am J Kidney Dis 1996, 28:292-295.
18. Fernandez-Miranda C., Rubio R., Pulido F. Development of acquired immune deficiency syndrome in a patient with systemic lupus erythematosus. J Rheumatol 1996, 23:1308.
19. Fox R.A., Isenberg D.A. Human immunodeficiency virus infection in systemic lupus erythematosus. Arthritis Rheum 1997, 40:1168-1172.
20. Chang B.G., Markowitz G.S., Seshan S.V., Seigle R.L., D'Agatti V.D. Renal manifestations of concurrent systemic lupus erythematosus and HIV infections. Am J Kidney Dis 1999, 33:441-449.
21. Maradona J.A., Carton J.A., Asensi V. Myastenia gravis and systemic lupus erythematosus in association with human immunodeficiency virus infection. Clin Infect Dis 1995, 20:1577-1578.
22. Cimmino M.A., DeMaria A., Moggiana G., Parisi M., Querci G., Accardo S. HIV infection in a male patient with systemic lupus erythematosus. Clin Exp Rheumatol 1996, 14:317-320.
23. Smith P.R., D'cruz D., Raftery M.J., Dodd S.M., Helbert M., Skinner C.J. Drug-induced lupus nephritis in HIV infection. Rheumatology 1999, 39:1047-1048.
24. Clutterbuck D.J., Watson J., De Ruitter A., Godfrey T., Bradbeer C. Presence of HIV infection in patients diagnosed with systemic lupus erythematosus. Rheumatology 2000, 39:1047-1048.
25. Diri E., Lipsky P.E., Berggren R.E. Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. J Rheumatol 2000, 27:2711-2714.
26. Mialou V., Bertrand Y., Bouvier R., Nochy D., Fabien N., Nicoud P., et al. Lupus nephritis in a child with AIDS. Am J Kidney Dis 2001, 37:E27.
27. Daikh B.E., Holyst M.M. Lupus-specific autoantibodies in a concomitant human immunodeficiency virus and systemic lupus erythematosus: case report and literature review. Semin Arthritis Rheum 2001, 30:418-425.
28. O'Keefe K., Edelheit B., Onel K., Tantawi M., Johann-Liang R. Systemic lupus erythematosus in a pediatric patient with congenital acquired immunodeficiency syndrome. Pediatr Infect Dis J 2001, 20:450-452.
29. Drake W.P., Byrd V.M., Olsen N.J. Reactivation of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for acquired immunodeficiency syndrome. J Clin Rheumatol 2003, 9:176-180.
30. Wanchu A., Sud A., Singh S., Bambery P. Human immunodeficiency virus infection in a patient with systemic lupus erythematosus. J Assoc Physicians India 2003, 51:1102-1104.
31. Calza L., Manfredi R., Colangeli V., D'Antuono A., Passarini B., Chiodo F. Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy. Int J STD AIDS 2003, 14:356-359.
32. Gould T., Tikly M. Systemic lupus erythematosus in a patient with human immunodeficiency virus infection-challenges in diagnosis and management. Clin Rheumatol 2004, 23:166-169.
33. Palacios R., Santos J., Valdivielso P., Marquez M. Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus 2002, 11:60-63.
34. Hazarika I., Chakravarty B.P., Dutta S., Mahanta N. Emergence of manifestations of HIV infection in a case of systemic lupus eythematosus following treatment with intravenous cyclophosphamide. Clin Rheumatol 2005, 25:98-100.
35. Colon M., Martinez D.E. Clinical remission of systemic lupus erythematosus after human immunodeficiency virus infection. P R Health Sci J 2007, 26:79.
36. Chalom E.C., Rezaee F., Mendelson J. Pediatric patient with systemic lupus erythematosus and congenital acquired immunodeficiency syndrome: an unusual case and a review of literature. Pediatr Rheumatol Online J 2008, 6:7.
37. Jakez-Ocampo J., Carrillo-Maravilla E., Richaud-Patin Y., Soto-Vega E., Atisha-Fregoso Y., Llorente L. An unusual multiplex systemic lupus erythematosus family with high prevalence of nephropathy, late-onset disease, and one member with disease-onset post HIV-therapy. J Clin Rheumatol 2008, 14:34-37.
38. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
39. Weening J.J., D'Agati V.D., Schwarts M.M., Seshan S.V., Alpers C.E., Appel G.B., et al. The classification of glomerulonephritis in systemic lupus nephritis revisited. J Am Soc Nephrol 2004, 15:241-250.
40. Austin H.A., Boumpas D.T., Vaughan E.M., Balow J.E. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 1994, 45:544-550.
41. Diamond B., Katz J.B., Aranov C., Lustgarten D., Scarff M.D. The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 1992, 10:731-757.
42. Mohan C., Adams S., Stanik V., Datta S.K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993, 177:1367-1381.
43. Aran A.A., Putterman C. Treatment of lupus nephritis: facing the era of immunotherapy. Panminerva Med 2008, 50:235-245.
44. Wofsy D., Seaman W.E. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. J Immunol 1987, 138:3247-3253.
45. Wang X., Huang W., Mihara M., Sinha J., Davidson A. Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus. J Immunol 2002, 168:2046-2053.
46. Maganti R.M., Reveille J.D., Williams F.M. Therapy insight: the changing spectrum of rheumatic disease in HIV population. Nat Clin Pract Rheumatol 2008, 4:428-438.
47. D'Agati V., Appel G.B. Renal pathology of human immunodeficiency virus infection. Semin Nephrol 1998, 18:406-421.
48. Haas M., Kaul S., Eustace J.A. HIV-associated immune complex glomerulonephritis with "lupus-like" features: a clinicopathologic study of 14 cases. Kidney Int 2005, 67:1381-1390.
49. Tabechian D., Pattanaik D., Suresh U., Cohn S.E., Nadasdy T. Lupus-like nephritis in an HIV-positive patient: report of a case and review of the literature. Clin Nephrol 2003, 60:187-194.
50. Wrone E.M., Carey H., Reilly R.F. Glomerular lesions in HIV-infected patients. Yale J Biol Med 1997, 70:161-173.
51. Sekigawa I., Kaneko H., Hishikawa T., Hashimoto H., Hirose S., Kaneko Y., et al. HIV infection and SLE: Their pathogenic relationship. Clin Exp Rheum 1998, 16:175-180.
52. Gourley M.F., Austin H.A., Scott D., Yarboro C.H., Vaughn E.M., Muir J., et al. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Int Med 1996, 125:549-557.
53. Boumpas D.T., Austin H.A., Vaughn E.M., Klippel J.H., Steinberg A.D., Yarboro C.H., et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophophamide in severe lupus nephritis. Lancet 1992, 340:741-745.
54. Alonso C.M., Lozada C.J. Effects of IV cyclophosphamide on HIV viral replication in a patient with systemic lupus erythematosus. Clin Exp Rheumatol 2000, 18:510-512.
55. Illei G.G., Austin H.A., Crane M., Collins L., Gourley M.F., Yarboro C.H., et al. Combination therapy with pulse Cyclophosphamide plus pulse Methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Int Med 2001, 135:248-257.
56. Haroon N., Inman R.D. Infectious complications of biological therapy. Curr Opin Rheumatol 2009, 21:397-403.
57. Cepeda E.J., Williams F.M., Ishimori M.L., Weisman M.H., Reveille J.D. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease. Ann Rheum Dis 2008, 67:710-712.
58. Boue F., Gabarre J., Gisselbrecht C., Reynes J., Cheret A., Bonnet F., et al. Phase II trial of CHOP plus Rituximab in patients with HIV-associated non-Hodgkin's lymphoma. J Clin Oncol 2006, 24:4123-4128.
59. Marcelin A., Aaron L., Mateus C., Gyan E., Gorin I., Viard J.P., et al. Rituximab therapy for HIV-associated Castleman disease. Blood 2003, 102:2786-2788.
60. Ross C.L., Hunt B.J., Wyncoll D., Hodgkiss A., Peters B. HIV, thrombocytopaenic purpura and Rituximab in a violent noncompliant patient. Blood Coagul Fibrinolysis 2009, 20:157-160.
61. Ginzler E.M., Aranow C. Mycophenolate Mofetil in lupus nephritis. Lupus 2005, 14:59-64.
62. Margolis D., Heredia A., Gaywee J., Oldach D., Drusano G., Redfield R. Abacavir and mycophenolic acid, an inhibitor of inosine-monophosphate dehydrogenase, have profound and synergistic anti-HIV activity. J Acquir Immune Defic Syndr 1999, 21:362-370.
63. Wrisekoop N., Sankatsing S.U., Jansen C.A., Roos M.T., Otto S., Schuttemaker H., et al. No detrimental immunological effects of mycophenolate mofetil and HAART in treatment-naïve acute and chronic HIV-1-infected patients. AIDS Res Hum Retroviruses 2005, 21:991-996.
64. Coull J.J., Turner D., Melby T., Betts M.R., Lanier R., Margolis D. A pilot study of the use of mycopenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection. J Acquir Immune Defic Syndr 2001, 26:423-434.
65. Garcia F., Plana M., Arnendo M., Brunet M., Castro P., Gil C., et al. Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection. J Acquir Immune Defic Syndr 2004, 36:823-830.
66. Stock P.G., Roland M.E., Carlson L., Freise C.E., Roberts J.P., Hirose R., et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 2003, 76:370-375.